相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
A. Bardia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP- and immune-checkpoint-inhibitors
Giovanna Garufi et al.
EXPERT OPINION ON PHARMACOTHERAPY (2020)
Predictors of Distant Metastases in Triple-Negative Breast Cancer Without Pathologic Complete Response After Neoadjuvant Chemotherapy
William R. Kennedy et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Pembrolizumab for Early Triple-Negative Breast Cancer
Peter Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Identification of synergistic drug combinations using breast cancer patient-derived xenografts
Tia H. Turner et al.
SCIENTIFIC REPORTS (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Quantitative assessment of breast cancer liver metastasis expansion with patient-derived xenografts
Mohammad A. Alzubi et al.
CLINICAL & EXPERIMENTAL METASTASIS (2019)
Iduronate-2-Sulfatase-Regulated Dermatan Sulfate Levels Potentiate the Invasion of Breast Cancer Epithelia through Collagen Matrix
Vishal Singh et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Triple negative breast cancer and platinum-based systemic treatment: a meta-analysis and systematic review
Jessa Gilda P. Pandy et al.
BMC CANCER (2019)
Glycans as Ligands in Bioinorganic Chemistry. Probing the Interaction of a Trinuclear Platinum Anticancer Complex with Defined Monosaccharide Fragments of Heparan Sulfate
Anil Kumar Gorle et al.
INORGANIC CHEMISTRY (2019)
How I treat metastatic triple-negative breast cancer
Rafael Caparica et al.
ESMO OPEN (2019)
Separation of breast cancer and organ microenvironment transcriptomes in metastases
Mohammad A. Alzubi et al.
BREAST CANCER RESEARCH (2019)
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
F. Cardoso et al.
ANNALS OF ONCOLOGY (2018)
Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer
Tia H. Turner et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Immunohistochemical and Image Analysis-Based Study Shows That Several Immune Checkpoints are Co-expressed in Non-Small Cell Lung Carcinoma Tumors
Edwin Roger Parra et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
Andrew Tutt et al.
NATURE MEDICINE (2018)
The exostosin family of glycosyltransferases: mRNA expression profiles and heparan sulphate structure in human breast carcinoma cell lines
Lawrence F. Sembajwe et al.
BIOSCIENCE REPORTS (2018)
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixto
S. Loibl et al.
ANNALS OF ONCOLOGY (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies
Ji Hyun Park et al.
ESMO OPEN (2018)
A validated gRNA library for CRISPR/Cas9 targeting of the human glycosyltransferase genome
Yoshiki Narimatsu et al.
GLYCOBIOLOGY (2018)
Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer
Jamaal A. Rehman et al.
MODERN PATHOLOGY (2017)
Murine breast cancer mastectomy model that predicts patient outcomes for drug development
Eriko Katsuta et al.
JOURNAL OF SURGICAL RESEARCH (2017)
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
N. Masuda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiangiogenic platinum through glycan targeting
Erica J. Peterson et al.
CHEMICAL SCIENCE (2017)
PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison
Joel C. Sunshine et al.
CLINICAL CANCER RESEARCH (2017)
Short SULF1/SULF2 splice variants predominate in mammary tumours with a potential to facilitate receptor tyrosine kinase-mediated cell signalling
Roop M. S. Gill et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2016)
NSG Mice Provide a Better Spontaneous Model of Breast Cancer Metastasis than Athymic (Nude) Mice
Madhavi Puchalapalli et al.
PLOS ONE (2016)
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein
Ali Salanti et al.
CANCER CELL (2015)
Multi-platinum anti-cancer agents. Substitution-inert compounds for tumor selectivity and new targets
N. P. Farrell
CHEMICAL SOCIETY REVIEWS (2015)
Solution studies on DNA interactions of substitution-inert platinum complexes mediated via the phosphate clamp
Y. Qu et al.
DALTON TRANSACTIONS (2015)
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao et al.
NATURE MEDICINE (2015)
Glycosaminoglycans: key players in cancer cell biology and treatment
Nikos Afratis et al.
FEBS JOURNAL (2012)
Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo
Ikuhiko Nakase et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Heparan Sulfate Proteoglycan-Mediated Entry Pathway for Charged Tri-Platinum Compounds: Differential Cellular Accumulation Mechanisms for Platinum
Heveline Silva et al.
MOLECULAR PHARMACEUTICS (2012)
A Structural Analysis of Glycosaminoglycans from Lethal and Nonlethal Breast Cancer Tissues: Toward a Novel Class of Theragnostics for Personalized Medicine in Oncology?
Amanda Weyers et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Breast Cancer Screening and Diagnosis
Therese B. Bevers et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
Immunohistochemical expression of heparan sulfate correlates with stromal cell proliferation in breast phyllodes tumors
Chuay-Yeng Koo et al.
MODERN PATHOLOGY (2006)
Estrogen receptor positive breast cancer metastasis: Altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes
Joshua Chuck Harrell et al.
CANCER RESEARCH (2006)
The sweet and sour of cancer: Glycans as novel therapeutic targets
MM Fuster et al.
NATURE REVIEWS CANCER (2005)
A phase I study of the trinuclear platinum compound, BBR 3464, in combination with protracted venous infusional 5-fluorouracil in patients with advanced cancer
C Gourley et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
DNA interstrand cross-links of the novel antitumor trinuclear platinum complex BBR3464 - Conformation, recognition by high mobility group domain proteins, and nucleotide excision
J Kasparkova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464
J Zehnulova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
